论文部分内容阅读
本文应用爱维治治疗脑梗塞60例,通过对比及临床观察,疗效满意。现报道如下。 1 资料与方法 1.1 病例选择:共120例脑梗塞患者,随机分为治疗组60例和对照组60例。全部病例均符合1995年第四届脑血管病学术会议通过的诊断标准。所有病例均处于脑梗塞急性期,均有不同程度的肢体瘫痪,并经头颅CT扫描证实有脑梗塞灶。 1.2 一般资料:治疗组60例,男42例,女18例,年龄55～78岁,平均64.7岁。对照组60例,男38例,女22例,年龄56～80岁,平均63.8岁。两组患者病情程度、发病和开始给药时间基本相同,其既往史和并发症评分,经计算其平均积分相近,说明两组患者具有可比性。根据1995年全国第四届脑
In this paper, Aventis treatment of 60 cases of cerebral infarction, through the comparison and clinical observation, the effect is satisfactory. Report as follows now. 1 Materials and Methods 1.1 Case Selection: a total of 120 patients with cerebral infarction were randomly divided into treatment group 60 cases and control group 60 cases. All the cases were in line with the diagnostic criteria adopted by the Fourth Academic Conference on Cerebrovascular Diseases in 1995. All cases were in the acute stage of cerebral infarction, both have different degrees of limb paralysis, and confirmed by cranial CT scan of cerebral infarction. 1.2 General Information: The treatment group of 60 patients, 42 males and 18 females, aged 55 to 78 years, an average of 64.7 years old. The control group of 60 patients, 38 males and 22 females, aged 56 to 80 years, mean 63.8 years. Two groups of patients with disease severity, onset and start of administration time is basically the same, its past history and complications score, calculated by the average integral similar, indicating that the two groups of patients with comparable. According to the 1995 Fourth National Brain